Nikhil Vora Portfolio: Top Holdings and Sector Weights
Nikhil Vora’s Portfolio at a Glance
Nikhil Vora’s disclosed Indian portfolio is worth Rs 248.24 crore across 6 stocks, up 16.69% this quarter. That’s a fairly concentrated portfolio, with a clear tilt toward consumer facing businesses.
The quick summary: heavy weighting toward FMCG and pharmaceuticals, spread across a small number of positions rather than a broad, diversified book.
Who Is Nikhil Vora
Nikhil Vora is known in Indian investing and business circles as the founder of Storied Boat Consulting and Sixth Sense Ventures, an investment platform focused on consumer businesses. He built his early career and public profile in equity research, developing a reputation for deep sector knowledge around consumer facing companies.
That research background, particularly around FMCG (fast moving consumer goods) and consumer trends, lines up closely with the sector tilt visible in his disclosed portfolio today.
Investors who move from research roles into direct investing often carry their sector expertise with them, choosing to back companies in the space they know best rather than spreading bets across unfamiliar industries. Vora’s disclosed public equity holdings appear to follow that same pattern.
Sector Breakdown
Vora’s portfolio is heavily weighted toward consumer and healthcare related sectors.
| Sector | Weight |
|---|---|
| FMCG | 52.97% |
| Pharmaceuticals & Biotechnology | 27.86% |
| Food, Beverages & Tobacco | 13.7% |
Together, these three sectors make up over 94% of the total portfolio value. FMCG alone is more than half the book, with Pharmaceuticals & Biotechnology as a strong secondary theme.
What This Sector Mix Suggests
A portfolio this weighted toward FMCG, pharma, and food and beverages points clearly toward consumer sector expertise, which lines up with Vora’s known background in consumer focused equity research and investing.
With just 6 stocks and nearly 95% of the value in three closely related sectors (all broadly tied to consumer demand and health), this looks like a portfolio built around a specific area of deep knowledge rather than broad market diversification. Concentrated, sector focused portfolios like this tend to perform well when the investor’s area of expertise is in favor, but they can also lag broader indices when that sector cools off.
Top Holdings
| Stock | Value (Rs Cr) |
|---|---|
| Hindustan Foods | 131.49 |
| Fredun Pharmaceuticals | 69.17 |
| Modi Naturals | 34.0 |
Hindustan Foods alone makes up about 53% of the entire portfolio, closely mirroring the FMCG sector weight seen above. Hindustan Foods works as a contract manufacturer for consumer goods brands, producing food, beverage, and personal care products for other companies.
Fredun Pharmaceuticals, a pharmaceutical manufacturer, is the second largest holding, lining up with the Pharmaceuticals & Biotechnology sector weight. Modi Naturals, involved in edible oils and food products, rounds out the top three and ties into the Food, Beverages & Tobacco sector weighting.
These three holdings together account for roughly Rs 234.66 crore, over 94% of the total Rs 248.24 crore portfolio, leaving only a small portion spread across the remaining three stocks.
Recent Activity
Recently Bought
- Inflame Appliances: stake increased by 2.24%
- Marvel Decor: stake increased by 1.87%
Recently Sold
- Suditi Industries: stake reduced by 0.41%
- Fredun Pharmaceuticals: stake reduced by 0.11%
The two recent buys, Inflame Appliances and Marvel Decor, both point to consumer durables and home furnishing categories, a bit different from the FMCG and pharma names that dominate his top holdings. That could suggest Vora is exploring adjacent consumer categories beyond his core FMCG and pharma weighting.
The Fredun Pharmaceuticals sale is worth noting since it’s also one of his top three holdings. A 0.11% reduction is small relative to the overall Rs 69.17 crore position, so it reads as a minor trim rather than a change in overall conviction.
Suditi Industries, involved in textiles, doesn’t appear among the top three holdings, which suggests it was already a smaller position before this quarter’s 0.41% reduction.
How Superstar Portfolio Tracking Works
This data is generated through SEBI’s shareholding disclosure requirement. When an individual’s stake in a listed Indian company crosses 1% of its total outstanding shares, the company must name that shareholder in its quarterly shareholding pattern filing.
Key mechanics worth understanding:
- Quarterly cadence: figures update once per quarter, tied to each company’s own filing calendar.
- 1% threshold: smaller stakes in other companies won’t show up here, even if they exist.
- Disclosure lag: an investor’s position may have shifted by the time this data becomes public.
For an investor like Vora running a consumer sector focused platform, this disclosed portfolio likely captures a meaningful part, though not necessarily all, of his direct personal equity holdings in this space.
What to Keep in Mind Before Acting on This Data
This kind of portfolio tracking is useful as a lens into where an experienced consumer sector investor sees opportunity, but it comes with real limits.
- Entry prices aren’t disclosed, so it’s not possible to calculate actual returns from this data.
- A portfolio this concentrated in FMCG and pharma carries real sector specific risk if consumer demand or healthcare regulation shifts unfavorably.
- Quarterly disclosure means this snapshot could already be a few months out of date.
- Position sizing reflects Vora’s specific expertise and risk tolerance, which may differ significantly from your own.
Use this as a starting point for further research into these companies, not as a ready made list of stocks to buy. Look at each company’s own financial disclosures, growth drivers, and competitive position before forming a view of your own.
Summary
Nikhil Vora’s disclosed portfolio is worth Rs 248.24 crore across 6 stocks, up 16.69% this quarter, with FMCG, Pharmaceuticals & Biotechnology, and Food, Beverages & Tobacco making up over 94% of the total. Hindustan Foods is his dominant holding at Rs 131.49 crore, followed by Fredun Pharmaceuticals and Modi Naturals. Recent activity shows fresh buying in Inflame Appliances and Marvel Decor, alongside small trims in Suditi Industries and Fredun Pharmaceuticals.
FAQ
What is Nikhil Vora’s biggest stock holding?
His largest disclosed holding is Hindustan Foods, worth Rs 131.49 crore, making up more than half of his total portfolio value.
Why is Nikhil Vora’s portfolio so weighted toward FMCG?
FMCG makes up 52.97% of his portfolio, largely driven by his top holding Hindustan Foods, a contract manufacturer for consumer goods brands.
What is Nikhil Vora’s background?
He is known as the founder of Storied Boat Consulting and Sixth Sense Ventures, with a career background in equity research focused on consumer sector companies.
Did Nikhil Vora buy or sell more stocks this quarter?
He added new positions in Inflame Appliances and Marvel Decor, while trimming small stakes in Suditi Industries and Fredun Pharmaceuticals.
How many stocks does Nikhil Vora hold in his disclosed portfolio?
His Superstar Portfolio data shows 6 disclosed stocks, concentrated mainly in FMCG, pharmaceuticals, and food and beverage companies.
Key Takeaways
- Nikhil Vora’s disclosed portfolio is worth Rs 248.24 crore across 6 stocks, up 16.69% this quarter.
- FMCG dominates the sector mix at 52.97%, followed by Pharmaceuticals & Biotechnology and Food, Beverages & Tobacco.
- Hindustan Foods is his largest holding, making up over half the portfolio value.
- Fredun Pharmaceuticals and Modi Naturals round out his top three holdings.
- Recent buys, Inflame Appliances and Marvel Decor, suggest exploration beyond his core FMCG and pharma focus.
- Recent selling was minor, touching Suditi Industries and Fredun Pharmaceuticals.
- Vora’s consumer sector research background lines up closely with his portfolio’s sector tilt.
